10/20/2015

Genekam Biotechnology AG

Genekam mycobacterium tuberculosis test with CE-IVD for human diagnostic applications

Genekam Biotechnology AG has developed a test for detection of Mycobacterium tuberculosis, cause of TB. It is a realtime PCR test. This is first test in the world, which is double check the bacterium in the sample.


Tuberculosis is one of disease, which infects millions of people around the world. Being a chronic disease, there is a need to check the people for this disease. Many times, TB is a compounding factor during immunosuppressive disease and the latency of this disease is another problem, hence people needs to be screened for such events.


Genekam Biotechnology AG has developed a test based on realtime PCR method, which is double check as it targets two different genes of pathogen. This assay is far better than conventional methods like tuberculin test, interferon test etc because these tests have problem of cross reactions leading to wrong results. The culturing of the samples need weeks to get the results against Genekam test, which needs only a few hours. It can be used on different kinds of samples like sputum, biopsies etc.


This kit is developed and manufactured through Genekam Biotechnology AG in Germany.